Table of contents

May 2005 Volume 2 No 5

Top

Editorial

Atrial fibrillation: an epidemiologic, scientific and clinical challenge

Valentin Fuster

225

doi:10.1038/ncpcardio0199 | Full Text | PDF (49K)

Top

Viewpoint

Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here?

Alan S Go

226

doi:10.1038/ncpcardio0198 | Full Text | PDF (69K)

Top

Research Highlights

Does distal microcirculatory protection improve PCI results?

228

doi:10.1038/ncpcardio0174 | Full Text | PDF (54K)

Benefits of cardiac resynchronization therapy

228

doi:10.1038/ncpcardio0175 | Full Text | PDF (54K)

Does aspirin protect women against cardiovascular disease?

228

doi:10.1038/ncpcardio0176 | Full Text | PDF (61K)

Predicting outcome in patients with asymptomatic mitral regurgitation

229

doi:10.1038/ncpcardio0177 | Full Text | PDF (54K)

High-risk acute coronary syndromes: cost-effectiveness of clopidogrel plus aspirin

229

doi:10.1038/ncpcardio0178 | Full Text | PDF (62K)

Right-ventricular function after acute myocardial infarction

230

doi:10.1038/ncpcardio0179 | Full Text | PDF (55K)

Obstructive sleep apnea-hypopnea and cardiovascular risk

230

doi:10.1038/ncpcardio0180 | Full Text | PDF (62K)

Acute myocardial infarction: invasive versus medical treatment

231

doi:10.1038/ncpcardio0181 | Full Text | PDF (54K)

Evidence Based Medicine

Prognostic value of BNP in heart failure

231

doi:10.1038/ncpcardio0182 | Full Text | PDF (61K)

Value of screening for abdominal aortic aneurysms

232

doi:10.1038/ncpcardio0183 | Full Text | PDF (54K)

Leukocyte count in cardiovascular risk assessment

232

doi:10.1038/ncpcardio0184 | Full Text | PDF (54K)

Do thiazide diuretics increase the risk of gallbladder disease?

232

doi:10.1038/ncpcardio0185 | Full Text | PDF (60K)

HOPE-TOO results: vitamin E supplements do not protect against cancer or cardiovascular disease

233

doi:10.1038/ncpcardio0186 | Full Text | PDF (53K)

Top

Practice Points

Can niacin slow the development of atherosclerosis in coronary artery disease patients already taking statins?

B Greg Brown

234

doi:10.1038/ncpcardio0189 | Full Text | PDF (70K)

Does losartan reduce the risk of stroke in patients with hypertension?

Thomas Unger

236

doi:10.1038/ncpcardio0197 | Full Text | PDF (71K)

Can the measurement of impaired flow-mediated dilation predict in-stent restenosis?

Matthew I Worthley, Francois Charbonneau and Todd J Anderson

238

doi:10.1038/ncpcardio0188 | Full Text | PDF (70K)

Is self-management of oral anticoagulation a feasible and safe option?

Jack E Ansell

240

doi:10.1038/ncpcardio0193 | Full Text | PDF (72K)

Can intravascular ultrasound detect left main coronary artery disease accurately?

Paul Schoenhagen

242

doi:10.1038/ncpcardio0191 | Full Text | PDF (72K)

Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?

Cornelis Kluft

244

doi:10.1038/ncpcardio0196 | Full Text | PDF (70K)

Top

Reviews

Continuing Medical Education

Atherosclerosis of the ascending aorta as a major determinant of the outcome of cardiac surgery

Per Bergman and Jan van der Linden

246

doi:10.1038/ncpcardio0192 | Full Text | PDF (113K)

Therapy Insight: heart disease and the insulin-resistant patient

Stuart A Cook, Tim Aitman and Rossi P Naoumova

252

doi:10.1038/ncpcardio0194 | Full Text | PDF (203K)

Technology Insight: randomized trials of off-pump versus on-pump coronary artery bypass surgery

Thoralf M Sundt

261

doi:10.1038/ncpcardio0190 | Full Text | PDF (127K)

Extra navigation

.

ADVERTISEMENT